Although the etiology of Parkinson's disease (PD) remains unclear, ample empirical
evidence suggests that oxidative stress is a major player in the development of PD and in 1 …

Current therapies for motor symptoms of Parkinson's disease (PD) are based on dopamine
replacement. However, the disease progression remains unaffected, because of continuous …

Parkinson's disease (PD) is a neurodegenerative movement disorder characterized by cell
loss in the substantia nigra resulting in striatal dopamine depletion. Although the cause of …

Oxidative stress has been implicated in the etiology of Parkinson's disease (PD) and in the 1-
methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) animal model of PD. In this report we …

Parkinson disease (PD) is a neurodegenerative disorder characterized by a selective loss of
dopaminergic neurons in the substantia nigra, and oxidative stress is thought to contribute to …

Oxidative stress has been implicated in the etiology of Parkinson's disease (PD) and in the 1-
methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) animal model of PD. It is known that …

The NF-E2-related factor-2 (Nrf2)/antioxidant response element (ARE) signaling pathway
regulates phase 2 detoxification genes, including a variety of antioxidative enzymes. We …

Although the pathogenic mechanisms of Parkinson's disease (PD) remain unclear, ample
empirical evidence suggests that oxidative stress is involved in the pathogenesis of this …

Oxidative stress and inflammation appear to play a critical role in the progression of
Parkinson's disease. As a result, there has been growing interest in antioxidant pathways …

Parkinson's disease (PD) is a complex neurodegenerative disorder featuring both motor and
nonmotor symptoms associated with a progressive loss of dopaminergic neurons in the …